[1]
L. Wang, Z. Teng, and D. Cai, “Retraction: Monotherapy with meropenem versus combination therapy of ceftazidime plus amikacin for empirical treatment of cancer patients with Febrile Neutropenic (FN): systematic review and meta-analysis”, EJO, vol. 20, no. 1, pp. 5-16, Sep. 2015.